Back
ESC Professional Premium Access

Screen-detected atrial fibrillation (AF) and 'micro-AF' after myocardial infarction in patients 70-82 years and risk of cardiovascular events in the OMEMI trial

Session: Treatment of atrial fibrillation in patient with coronary artery disease
Topic: Prevalence and Incidence of Atrial Fibrillation
Speaker: Doctor T. Berge (Oslo, NO)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Trygve Berge

Oslo University Hospital Ulleval, Oslo (Norway)
0 follower

4 more presentations in this session

Causes of death in patients with atrial fibrillation and a recent acute coronary syndrome or percutaneous coronary intervention: Insights from the AUGUSTUS trial

Speaker: Professor R. Lopes (Durham, US)

Access
Abstract
Slides
Thumbnail

Factors associated with progression of atrial fibrillation and impact on all-cause mortality: an ancillary analysis from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General

Speaker: Doctor M. Vitolo (Modena, IT)

Access
Abstract
Slides
Thumbnail

Determinants of post-operative atrial fibrillation in 1613 patients undergoing coronary artery bypass grafting in the Statin Therapy In Cardiac Surgery (STICS) trial

Speaker: Doctor R. Wijesurendra (Oxford, GB)

Access
Abstract
Slides
Thumbnail

Features of clinical complexity in european patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry

Speaker: Doctor M. Proietti (Milan, IT)

Access
Abstract
Slides
Thumbnail

Access the full session

Treatment of atrial fibrillation in patient with coronary artery disease

Speakers: Doctor T. Berge, Professor R. Lopes, Doctor M. Vitolo, Doctor R. Wijesurendra, Doctor M. Proietti
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb